Sichenzia Ross Friedman Ference LLP Represents Citius Pharmaceuticals Inc. in connection with its acquisition of LM Biosciences, Inc.
Press Release – New York, NY – March 8, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that it has represented Citius in its acquisition of LM Biosciences, Inc. (“LMB”). LMB is a late-stage specialty pharmaceutical company focused on the development and commercialization of critical care products with a concentration of anti-infective drugs.
The acquisition was an all stock transaction and included a $3 million investment by Citius’ Chairman of the Board. The Sichenzia Ross Friedman Ference LLP was led by Partners Arthur Marcus, Gregory Sichenzia and associate Nazia Khan.
- Sichenzia Ross Ference LLP Represents Document Security Systems, Inc. in Close of $3.4 Million Underwritten Public Offering of Common Stock - August 1, 2020
- Relief for Retirement Account Owners During COVID-19 - July 30, 2020
- Sichenzia Ross Ference LLP Represents Immuron Limited in $20 Million Registered Direct Offering - July 24, 2020